PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Standard chemoradiation often enriches drug-resistant tumor cell populations that can lead to recurrent and treatment-refractory disease. For instance, preclinical models of several cancers suggest that the cancer stem cell subpopulation becomes enriched and re-populates the tumor milieu following conventional therapies. Here, we show evidence that photodynamic therapy (PDT) is effective against several patient-derived glioblastoma stem cell cultures. Moreover, sub-lethal PDT results in re-sensitization of cancer cell phenotypes with induced drug-resistance to chemotherapy. This talk will also introduce some of our efforts to establish a new program aimed at developing personalized and targeted PDT to overcome drug-resistance.
Bryan Q. Spring
"Photodynamic therapy of brain tumor stem cells overcomes drug-resistance in preclinical models (Conference Presentation)", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110701E (14 August 2019); https://doi.org/10.1117/12.2527769
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Bryan Q. Spring, "Photodynamic therapy of brain tumor stem cells overcomes drug-resistance in preclinical models (Conference Presentation)," Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 110701E (14 August 2019); https://doi.org/10.1117/12.2527769